Tanaka et al., 2020 - Google Patents
Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6Tanaka et al., 2020
View HTML- Document ID
- 8361136463310124351
- Author
- Tanaka R
- Ichimura Y
- Kubota N
- Saito A
- Nakamura Y
- Ishitsuka Y
- Watanabe R
- Fujisawa Y
- Kanzaki M
- Mizuno S
- Takahashi S
- Fujimoto M
- Okiyama N
- Publication year
- Publication venue
- Communications Biology
External Links
Snippet
Use of immune checkpoint inhibitors that target programmed cell death-1 (PD-1) can lead to various autoimmune-related adverse events (irAEs) including psoriasis-like dermatitis. Our observations on human samples indicated enhanced epidermal infiltration of CD8 T cells …
- 201000004624 dermatitis 0 title abstract description 113
Classifications
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
- G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
- G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
- G01N33/5047—Cells of the immune system
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay
- G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Tanaka et al. | Activation of CD8 T cells accelerates anti-PD-1 antibody-induced psoriasis-like dermatitis through IL-6 | |
| Campesato et al. | Blockade of the AHR restricts a Treg-macrophage suppressive axis induced by L-Kynurenine | |
| Walens et al. | CCL5 promotes breast cancer recurrence through macrophage recruitment in residual tumors | |
| Zheng et al. | Lung mesenchymal stromal cells influenced by Th2 cytokines mobilize neutrophils and facilitate metastasis by producing complement C3 | |
| Pascual-García et al. | LIF regulates CXCL9 in tumor-associated macrophages and prevents CD8+ T cell tumor-infiltration impairing anti-PD1 therapy | |
| Dodagatta-Marri et al. | α-PD-1 therapy elevates Treg/Th balance and increases tumor cell pSmad3 that are both targeted by α-TGFβ antibody to promote durable rejection and immunity in squamous cell carcinomas | |
| Cui et al. | Activation of JUN in fibroblasts promotes pro-fibrotic programme and modulates protective immunity | |
| Zhai et al. | Tumor cell IDO enhances immune suppression and decreases survival independent of tryptophan metabolism in glioblastoma | |
| Mugarza et al. | Therapeutic KRASG12C inhibition drives effective interferon-mediated antitumor immunity in immunogenic lung cancers | |
| Li et al. | Immune-checkpoint protein VISTA critically regulates the IL-23/IL-17 inflammatory axis | |
| Zhai et al. | Infiltrating T cells increase IDO1 expression in glioblastoma and contribute to decreased patient survival | |
| Chakievska et al. | IL-17A is functionally relevant and a potential therapeutic target in bullous pemphigoid | |
| Chatterjee et al. | Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation | |
| Gómez-Aleza et al. | Inhibition of RANK signaling in breast cancer induces an anti-tumor immune response orchestrated by CD8+ T cells | |
| Dai et al. | IL-23 limits the production of IL-2 and promotes autoimmunity in lupus | |
| Wallin et al. | Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma | |
| Liu et al. | Soluble PD-1 aggravates progression of collagen-induced arthritis through Th1 and Th17 pathways | |
| Belarif et al. | IL-7 receptor blockade blunts antigen-specific memory T cell responses and chronic inflammation in primates | |
| Kirchberger et al. | Innate lymphoid cells sustain colon cancer through production of interleukin-22 in a mouse model | |
| Liu et al. | T‐cell immunoglobulin mucin 3 blockade drives an antitumor immune response in head and neck cancer | |
| Torrey et al. | Targeted killing of TNFR2-expressing tumor cells and Tregs by TNFR2 antagonistic antibodies in advanced Sézary syndrome | |
| Kaesler et al. | Targeting tumor-resident mast cells for effective anti-melanoma immune responses | |
| In et al. | HEB is required for the specification of fetal IL-17-producing γδ T cells | |
| Li et al. | Regulatory T cells control toxicity in a humanized model of IL-2 therapy | |
| Spada et al. | NKG2D ligand overexpression in lupus nephritis correlates with increased NK cell activity and differentiation in kidneys but not in the periphery |